The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium–Derived Factor
Abstract
PURPOSE: To evaluate the impact of photodynamic therapy (PDT) on expression and distribution of vascular endothelial growth factor (VEGF), VEGF receptor (VEGFR)-3, and pigment epithelium-derived factor (PEDF). METHODS: Eyes of patients scheduled for enucleation due to untreatable malignancy served as study eyes (n = 4), age-matched donor eyes were used as the control (n = 4). PDT using verteporfin with the recommended standard parameters was applied to intact areas of the perimacular region. Lesions were classified by ophthalmoscopy, fluorescein angiography (FA), and indocyanine green angiography (ICGA), as well as light and electron microscopic (LM/EM) histology. Immunolabeling using specific antibodies against VEGF, VEGFR-3, and PEDF was performed in PDT-treated areas, untreated collateral areas in study eyes, and untreated areas of control eyes. Specimens were fixed in 4% paraformaldehyde and 1% glutaraldehyde and embedded in paraffin. Four-micrometer-thick sections were stained using the peroxidase-labeled streptavidin-biotin method. RESULTS: All PDT-treated areas demonstrated characteristic choroidal hypofluorescence by FA and ICGA. LM/EM histology revealed selective damage of choriocapillary endothelial cells. VEGF was expressed in the endothelial layer of choriocapillaries and focally within larger choroidal vessels in treated areas, but not in untreated areas. Sites with positive VEGF labeling also demonstrated upregulation of VEGFR-3. PEDF expression was localized to retinas in all eyes; however, PEDF staining of choroidal endothelial cells was specific for treated areas of study eyes. CONCLUSIONS: PDT using verteporfin induces a reproducible angiogenic response in elderly human eyes. VEGF, VEGFR-3, and PEDF expression is enhanced after PDT. Choroidal endothelial cells appear to be the primary site of angiogenic stimulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
The Role of Oxidative Stress in the Pathogenesis of Age-Related Macular Degeneration
Beatty, S., Koh, H.-H., Phil, M., Henson, D., & Boulton, M. (2000) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00140-5 · Cited by 2,051
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
Dawson, D. W., Volpert, O. V., Gillis, P., Crawford, S. E., Xu, H.-J., Benedict, W., & Bouck, N. P. (1999) · Science · doi:10.1126/science.285.5425.245 · Cited by 1,505
Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M., & Alitalo, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3566 · Cited by 1,423
Kvanta, A., Algvere, P., Berglin, L., & Seregard, S. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70522-7 · Cited by 620
Lopez, P. F., Sippy, B. D., Lambert, H. M., Thach, A. B., & Hinton, D. R. (1998) · Retina · doi:10.1097/00006982-199805000-00035 · Cited by 592
Schmidt-Erfurth, U., & Hasan, T. (2000) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00158-2 · Cited by 518
Self-citationVEGF is major stimulator in model of choroidal neovascularization.
Kwak, N., Okamoto, N., Wood, J. M., & Campochiaro, P. A. (2000) · PubMed · Cited by 442
Malecaze, F. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090230090028 · Cited by 364
Pigment epithelium‐derived factor inhibits retinal and choroidal neovascularization
Mori, K., Duh, E., Gehlbach, P., Ando, A., Takahashi, K., Pearlman, J., Mori, K., Yang, H. S., Zack, D. J., Ettyreddy, D., et al. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1114 · Cited by 337
Tolentino, M. J. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140172010 · Cited by 332
Duh, E. J., Yang, H. S., Suzuma, I., Miyagi, M., Youngman, E. M., Mori, K., Katai, M., Yan, L., Suzuma, K., West, K. A., et al. (2002) · PubMed · Cited by 304
Partanen, T. A., Alitalo, K., & Miettinen, M. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991201)86:11<2406::aid-cncr31>3.0.co;2-e · Cited by 304
Vascular Effects of Photodynamic Therapy
FINGAR, V. H. (1996) · Journal of Clinical Laser Medicine & Surgery · doi:10.1089/clm.1996.14.323 · Cited by 302
Growth factor localization in choroidal neovascular membranes of age-related macular degeneration.
Amin, R., Puklin, J. E., & Frank, R. N. (1994) · PubMed · Cited by 299
Schlötzer-Schrehardt, U., Viestenz, A., Naumann, G. O., Laqua, H., Michels, S., & Schmidt-Erfurth, U. (2002) · Graefe’s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-002-0517-4 · Cited by 278
Self-citationAntiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario, A., von Tiehl, K., Rucker, N., Schwarz, M. A., Gill, P. S., & Gomer, C. J. (2000) · PubMed · Cited by 256
PEDF: anti-angiogenic guardian of ocular function
Bouck, N. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02362-6 · Cited by 235
Photodynamic effects on choroidal neovascularization and physiological choroid.
Schmidt-Erfurth, U. M., Michels, S., BARBAZETTO, I. A., & Laqua, H. (2002) · PubMed · Cited by 234
Self-citationMori, K., Gehlbach, P. L., Yamamoto, S., Duh, E. J., Zack, D. J., Li, Q., Berns, K. I., Raisler, B. J., Hauswirth, W. W., & Campochiaro, P. A. (2002) · PubMed · Cited by 231
Liposomal Benzoporphyrin Derivative Verteporfin Photodynamic Therapy
Kramer, M., Miller, J. W., Michaud, N., Moulton, R. S., Hasan, T., Flotte, T. J., & Gragoudas, E. S. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30675-1 · Cited by 221
Vascular effects of photodynamic therapy.
Krammer, B. E. (2001) · PubMed · Cited by 219
Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration.
McLeod, D. S., Taomoto, M., Otsuji, T., Green, W. R., Sunness, J. S., & Lutty, G. A. (2002) · PubMed · Cited by 192
(2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.11.1443 · Cited by 178
Effect of Aging on Foveolar Choroidal Circulation
Grunwald, J. E., Hariprasad, S. M., & DuPont, J. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.2.150 · Cited by 178
Sequence of Early Vascular Events after Photodynamic Therapy
Michels, S., & Schmidt-Erfurth, U. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0604 · Cited by 165
Self-citationOgata, N., Wada, M., Otsuji, T., Jo, N., Tombran‐Tink, J., & Matsumura, M. (2002) · PubMed · Cited by 132
Husain, D., Kramer, M., Kenny, A. G., et al. (1999) · PubMed · Cited by 130
Witmer, A. N., Blaauwgeers, H. G. T., Weich, H. A., Alitalo, K. K., Vrensen, G. F. J. M., & Schlingemann, R. O. (2002) · PubMed · Cited by 121
Reinke, M. H., Canakis, C., Husain, D., Michaud, N. A., Flotte, T. J., Gragoudas, E. S., & Miller, J. W. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90401-3 · Cited by 119
Busch, T. M., Hahn, S. M., Evans, S. M., & Koch, C. J. (2000) · PubMed · Cited by 113
Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury
Ogata, N., Wang, L., Jo, N., et al. (2001) · Current Eye Research · doi:10.1076/ceyr.22.4.245.5506 · Cited by 103
Wada, M., Ogata, N., Otsuji, T., & Uyama, M. (1999) · Current Eye Research · doi:10.1076/ceyr.18.3.203.5368 · Cited by 98
Dimitroff, C. J., Klohs, W. D., Sharma, A., Pera, P. J., Driscoll, D. L., Veith, J. M., Steinkampf, R. W., Schroeder, M. C., Klutchko, S. R., Sumlin, A. B., et al. (1999) · Investigational New Drugs · doi:10.1023/a:1006367032156 · Cited by 96
Verteporfin in photodynamic therapy (VIP) study group
Ruiz–Oliva, F., & Corts, J. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)00972-7 · Cited by 88
Vinores, S. A., Küchle, M., Mahlow, J., Chiu, C., Green, W. R., & Campochiaro, P. A. (1995) · Europe PMC (PubMed Central) · Cited by 69
Zacks, D. N., Ezra, E., Terada, Y., Michaud, N. A., Connolly, E. J., Gragoudas, E. S., & Miller, J. W. (2002) · PubMed · Cited by 65
Ghazi, N. G., Jabbour, N. M., de la Cruz, Z. C., & GREEN, W. R. (2001) · Retina · doi:10.1097/00006982-200110000-00010 · Cited by 59
Hutchings, H., Maitre-Boube, M., Tombran‐Tink, J., & Plouët, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00548-x · Cited by 57
Schmidt-Erfurth, U. M., & Michels, S. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00452-4 · Cited by 57
Self-citationLipid Hydroperoxide Stimulates Subretinal Choroidal Neovascularization in the Rabbit
Tamai, K., Spaide, R. F., Ellis, E. A., Iwabuchi, S., Ogura, Y., & Armstrong, D. (2002) · Experimental Eye Research · doi:10.1006/exer.2001.1121 · Cited by 55
Expression of vascular endothelial growth factor in mouse tumours subjected to photodynamic therapy
Uehara, M., Inokuchi, T., Sano, K., & ZuoLin, W. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00243-x · Cited by 35
Cited by
Immonen, I., Seitsonen, S., Tommila, P., Kangas-Kontio, T., Kakko, S., Savolainen, E.-R., Savolainen, M. J., & Liinamaa, M. J. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.06.037 · Cited by 45
Spielberg, L., & Leys, A. (2010) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-009-1256-6 · Cited by 31
Metadata
- Authors
- Schmidt-Erfurth, U., Schlo¨tzer-Schrehard, U., Cursiefen, C., Michels, S., Beckendorf, A., & Naumann, G. O. H.
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2003-10-01
- Volume
- 44
- Issue
- 10
- Pages
- 4473
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2045317893
- Cited by
- 317
- References
- 45
- FWCI
- 19.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.